醫(yī)學(xué)遺傳學(xué)課件:11、Chapter 13 遺傳病的治療_第1頁(yè)
醫(yī)學(xué)遺傳學(xué)課件:11、Chapter 13 遺傳病的治療_第2頁(yè)
醫(yī)學(xué)遺傳學(xué)課件:11、Chapter 13 遺傳病的治療_第3頁(yè)
醫(yī)學(xué)遺傳學(xué)課件:11、Chapter 13 遺傳病的治療_第4頁(yè)
醫(yī)學(xué)遺傳學(xué)課件:11、Chapter 13 遺傳病的治療_第5頁(yè)
已閱讀5頁(yè),還剩71頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、http:/ 51 : DMD exon 51 skippingSpinraza : spinal muscular atrophy “Soon there will be no disease called breast cancer,” says Draghia-Akli. Instead, the catch-all term will be replaced by “a large number of rare diseases, each of which causes malignant growth in breast tissue and requires individual

2、 treatment”.遺傳診斷產(chǎn)前診斷癥狀前篩查DiversionDepletionLDL apheresis 分離術(shù)分離術(shù)cholestyramine消膽氨消膽氨InhibitionStatins他汀他汀GBA合成酶活性部位特異的分子伴侶治療活性部位特異的分子伴侶治療Active-Site-Specific Chaperone therapy1-deoxy-galactonojirimycin (DGJ) for FabryN-nonyl-deoxynojirimycin (NN-DNJ) for GaucherVX-770G551D耳毒性耳毒性, 腎毒性腎毒性,神經(jīng)肌肉阻斷神經(jīng)肌肉阻斷,

3、 變態(tài)反應(yīng)變態(tài)反應(yīng)Antisense-induced exon skippingLancet 2008; 371: 212033Figure 1. People unaffected by SMA possess two SMN genes; SMN1 (green rectangle) produces all the functional SMN protein required for a healthy nervous system, while SMN2 (blue rectangle) only produces a fraction of that (top left). SMN

4、-AS1 (red oval) is a naturally occurring molecule in the body that restricts the amount of SMN protein made from both SMN genes. SMA patients lack a functioning SMN1 gene and rely solely on SMN2 for the production of SMN protein, meaning that they have much lower levels of functional SMN Protein (to

5、p right).Figure 2. Spinraza (purple rectangle) is an antisense oligonucleotide (ASO) that specifically recognises the messenger RNA (mRNA) produced from the SMN2 gene (top left). The SMN2 mRNA is processed in a different manner when Spinraza is present, resulting in the production of more functional

6、 SMN protein from this backup SMN gene. The new therapeutic strategy identified by the Sumner laboratory uses an ASO to remove the SMN-AS1 molecule from the SMN2 gene, allowing the gene to produce greater quantities of mRNA (top right). This gives Spinraza more material to work with, and produces la

7、rger amounts of functional SMN protein than when Spinraza is administered on its own.GOF: gain of functionLOF: loss of function離體離體 ex vivo在體在體 in vivoViral genometransgene基因轉(zhuǎn)移的工具基因轉(zhuǎn)移的工具反轉(zhuǎn)錄病毒反轉(zhuǎn)錄病毒載體載體HSV病毒病毒載體載體AAV病毒病毒載體載體RNA病毒病毒載體載體腺病毒載體腺病毒載體痘病毒痘病毒載體載體EBV病毒病毒載體載體病毒載體的種類病毒載體的種類1 1、利用病毒天然的感染性進(jìn)入細(xì)胞,轉(zhuǎn)導(dǎo)效率高;、利用病毒天然的感染性進(jìn)入細(xì)胞,轉(zhuǎn)導(dǎo)效率高;2 2、復(fù)雜的裝配過(guò)程由細(xì)胞完成;、復(fù)雜的裝配過(guò)程由細(xì)胞完成;3 3、不同的病毒載體具有不同的表達(dá)特點(diǎn)。、不同的病毒載體具有不同的表達(dá)特點(diǎn)。存在的問(wèn)題

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論